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INTRODUCTION
Ribavirin (1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide), a synthetic nucleoside analog, is a broad-spectrum inhibitor of RNA and DNA viruses that is currently licensed for the treatment of severe respiratory syncytial virus (RSV) disease [1] and chronic hepatitis C virus (HCV) infection [2, 3] . Antiviral properties of ribavirin were ascribed to inhibition of inosine monophosphate dehydrogenase, interference with viral RNA capping reactions; inhibition of viral polymerase and induction of error catastrophe resulting from the accumulation of lethal mutations in viral genome [4] .
Apart from direct antiviral effects, ribavirin was reported to have immunomodulatory effects on different constituents of the immune system. Ribavirin induced a switch in T-helper (Th) cell phenotype from type 2 to type 1 [5] . In patients with chronic HCV infection, ribavirin was shown to exert anti-inflammatory effect by reducing the blood levels of interferon (IFN)-γ and the expression of IFN-γ by activated T cells [6] , thus thereby helping to suppress IFN-γ-driven T cell activation and liver damage [6] . In macrophages, ribavirin inhibited the induction of pro-inflammatory cytokines like interleukin (IL)-1β and tumor necrosis factor (TNF)-α [7] . In dendritic cells, ribavirin suppressed the production of TNF-α, IL-10, and IL-12(p70) [8] . In murine natural killer (NK) cells, ribavirin inhibited IFN-γ production in a dose-dependent manner [9] .
NK cells provide the first line of defense and substantially contribute to the elimination of virus-infected cells as well as antitumor immune response [10] . Moreover, IL-15 is known to play a pivotal role in NK cell development in vivo as well as in NK cell activation and proliferation and is secreted in response to infectious pathogens to mediate NK cytotoxicity [11] . IL-15 and IL-2 receptor gamma (IL-2Rγ) genes, both involved in lymphocyte activation and signaling, were reported to be down-regulated by ribavirin in RSVinfected human A549 pulmonary type II epithelial cells [12] . In NK cells, the IL-15 receptor includes IL-15Rα, IL-2/15Rβ and γ chain subunits (β and γ c subunits are shared with IL-2) 4 [11] . As IL-2 and IL-15 share common signaling components, most evidence suggests that the interaction of IL-2 or IL-15 with their respective receptor complex in various cell types leads to a series of similar if not identical signaling events [13] . IL-15Rβ is associated with Janus kinase (Jak)-1 and the γ c is associated with Jak-3, resulting in signal transducer and activator of transcription (STAT)-3 and STAT-5 phosphorylation respectively, following ligation with IL-15 [13] . IL-15 also activates the phosphorylation of STAT-1 [14, 15] . In addition to signaling via IL-15/IL-15R, NK cell activation is also tightly regulated by a delicate balance between signaling through inhibitory [killer immunoglobulin-like receptors (KIR), CD94-NK group 2, member A (NKG2A)] and activating receptors [natural cytotoxic receptors (NCRsNKp30, NKp44 and NKp46), NK group 2, member D (NKG2D) and DNAX accessory molecule-1 (DNAM-1)] [10] . The expressions of these receptors are up-regulated upon treatment with IL-15 [16, 17] . Inhibitory receptors consist of a single polypeptide containing cytoplasmic immunoreceptor tyrosine-based inhibitory motifs that recruit tyrosine phosphatases and abort signaling. On the other hand, activating receptors typically couple to signaling adaptors that contain either an immunoreceptor tyrosine-based activating motif (ITAM, such as DAP12, FcRγ or CD3δ ) or "YXNM" motif, where "X" is any amino acid (such as the signaling adaptor DAP10) through interactions specified by their transmembrane regions [18] . Interestingly, signaling through DAP10, an adaptor that transmits important signals for NKG2D [19] , was shown to be coupled to IL-15R signaling pathway [20] . Here, DAP10 was shown to specifically bind β-and γ-chains of IL15R [20] .
In this report, we have studied the direct effect of ribavirin on effector functions (including cytolytic activity and IFN-γ production) of IL-15-activated human NK cells as well as molecular mechanisms by which ribavirin influence NK cell functions. We observed that ribavirin exerts immunomodulatory activities on NK cells by down-regulating the expression of IL-15Rβ and γ and thus inhibiting downstream events involved in NK cell signaling (IL-M a n u s c r i p t   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   5 15-activation of Jak/STAT pathway) and degranulation [extracellular signal-regulated kinase (ERK1/2) and c-Jun N-terminal kinase (JNK) signaling pathways].
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MATERIALS AND METHODS
Reagents and monoclonal antibodies
Ribavirin (Virazole®) was obtained from Valeant Pharmaceuticals Germany GmbH (Eschborn, Germany), DETA NONO-ate and tetrahydrobiopterin were purchased from Sigma-Aldrich (Taufkirchen, Germany), recombinant human IL-15 was from Cell Concepts (Umkirch, Germany). The following phycoerythrin (PE)-conjugated anti-human monoclonal antibodies (mAbs) were used: NKp30, NKp44, NKp46, NKG2D, DNAM-1, KIR-KIR2DL2/DL3 and KIR3DL1, all from Miltenyi Biotec (Bergisch Gladbach, Germany), NKG2A, IL-2Rβ and IL-2Rγ were from R&D systems (Wiesbaden, Germany), perforin and granzyme B were from Abcam (Cambridge, UK). Unconjugated IL-15Rα was from R&D systems (Wiesbaden, Germany). Fluorescein isothiocynate (FITC)-conjugated lymphocyte function antigen (LFA)-1 was from BD Pharmingen (San Diego, CA, USA). For redirected killing experiments, purified NKp30, NKp44, NKp46, NKG2D, DNAM-1 mAb (Miltenyi Biotec, Bergisch Gladbach, Germany) were used.
Cells
Human erythroleukemic K562 cell line was obtained from American type culture collection (ATCC; Manassas, VA, USA). P815 FcγR + murine cell line was from DSMZ, Braunschweig, Germany. K562 cell line was grown in Iscove"s Modified Dulbecco"s Medium (IMDM)
supplemented with 20% fetal calf serum (FCS), while P815 cell line was grown in IMDM supplemented with 10% FCS. Media and supplements were from Seromed (Berlin, Germany).
Polyclonal NK cell preparation
Human PBMCs were isolated from the blood of healthy volunteers by Ficoll-Hypaque centrifugation followed by separation using the MACS NK cell isolation kit II (Miltenyi A c c e p t e d M a n u s c r i p t   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   7 analysis to determine purity of NK cells showed that more than 95% of the cells were 
Cytotoxicity assay and Flow cytofluorometric analysis
Cytotoxicity of NK cells was determined by a 4 h coupled luminescent method using the "ACELLA-TOX TM " kit (Cell Technology, Mountain View, CA, USA), as described [21] .
K562 and P815 FcγR + cell lines were used as target cells. For redirected killing experiments, 1 µg/ml of the corresponding purified mAb was used. Flow cytometry (FACS Calibur; Becton
Dickinson, Mountain View, CA, USA) was used for cell surface expression analysis.
Cell cycle analysis
Cell cycle was determined using a commercial kit (BD Biosciences, San Jose, CA, USA)
following the manufacturer"s instructions as described previously [22] .
Viability assay
The effect of ribavirin on viability of IL-15-activated NK cells was assessed using CELL TITRE-GLO™ luminescent cell viability assay (Promega, Mannheim, Germany). This assay is a homogenous method of determining the number of viable cells in culture based on the quantitation of ATP present, which signals the presence of metabolically active cells. After 5 days treatment with ribavirin 100 µl cell suspension were incubated with 100 μl of CELL TITRE-GLO™ reagent and contents were allowed to mix on an orbital shaker in accordance with the assay protocols, this resulted in cell lysis and generation of a luminescent signal proportional to the amount of ATP present. The amount of ATP is proportional to the number 
Western blot
Cells were cultured in IL-15 and in the presence or absence of ribavirin for 18 h and 5 days.
Afterwards, Western blot analysis was performed as previously described [24] . Briefly, cell lysates were subjected to SDS-PAGE before transfer to nitrocellulose membranes (Schleicher & Schuell, Dassel, Germany) using the Mini-Protean II system (Bio-Rad, Munich, Germany).
After transfer, blots were blocked in tris-buffered saline (TBS) blocking buffer containing 3%
bovine serum albumin for 1 h at room temperature to saturate the non-specific protein-binding sites on the nitrocellulose membrane. The following primary rabbit polyclonal Abs were used:
Jak-1, phospho-Jak-1 (tyrosine (Tyr)1022/1023), Jak-3, STAT-1, phospho-STAT-1 (Tyr701),
STAT-3, phospho-STAT-3 (Tyr705), STAT-5, phospho-STAT-5 (Tyr694), ERK1/2, phospho-ERK1/2, JNK, phospho-JNK -all from Cell Signaling (Beverly, MA, USA).
Phospho-Jak-3 (Tyr980) was from Santa Cruz biotechnology (Santa Cruz, CA, USA), mouse 
Statistics
Values presented are the mean ± standard error of mean (S.E.M) of at least three experiments.
Comparisons between two groups were performed using Student"s t-test. P-values lower than 0.05 were considered to be significant.
Measurement of transcription factor activation
The activation of nuclear factor kappa B (NFκB) p50, NFκB p65, T-box expressed in T cells A c c e p t e d M a n u s c r i p t 
Effect of RBV on viability of NK cells
We previously demonstrated that ribavirin neither induced a block in the cell cycle progression nor exerted cytotoxic effects in primary HUVEC at concentrations up to 20 µg/ml and 100 µg/ml respectively [25] . We therefore studied effects of ribavirin at concentrations ranging from 5 µg/ml to 80 µg/ml on viability of IL-15-activated NK cells. was however reduced to 59% at 80 µg/ml ribavirin concentration.
Ribavirin suppresses NK cell cytotoxicity and IFN-γ production
The role of ribavirin on NK cell cytotoxicity was next investigated. Both freshly isolated NK cells and IL-15-activated NK cells were treated with 5 µg/ml, 10 µg/ml, and 20 µg/ml ribavirin for 5 days after which the cytotoxicity against K562 cells was determined using a 4 h coupled luminescent method [21] . The results obtained show that ribavirin significantly suppressed IL-15-activated NK cell lysis of K562 in a dose-dependent manner ( Fig. 2A) . The % inhibition in comparison to control were 21%, 34.2%, and 65.8% respectively for 5, 10, and 20 µg/ml ribavirin at an effector/target (E/T) ratio of 2:1. At E/T ratio of 4:1, the % inhibition was 18.6%, 39%, and 59.3% respectively for 5, 10, and 20 µg/ml RBV ( Fig. 2A ).
On the other hand, ribavirin did not influence lysis of K562 target cells by freshly isolated NK The % inhibition in comparison to control was 28.1%, 49.1%, and 67.7% respectively for 5, 10, and 20 µg/ml ribavirin ( Fig. 2C ). As more than 50% inhibition of NK lytic capacity and cytokine production was achieved by 20 µg/ml ribavirin treatment, and at this concentration ribavirin was not toxic to the cells, further experiments to clarify the mechanisms by which ribavirin inhibits IL-15-activated NK cell function were performed using 20 µg/ml.
Ribavirin suppresses NK cell cytotoxicity by mechanisms other than tetrahydrobiopterin or NO inhibition
Previous studies indicated that ribavirin acts by inhibition of tetrahydrobiopterin, a cofactor of NO synthase enzymes, thereby leading to suppression of NO synthesis [25, 28] . We therefore investigated whether ribavirin suppressed IL-15-activated NK cell cytotoxicity by tetrahydrobiopterin inhibition. For this purpose, we exogenously added tetrahydrobiopterin or NO to ribavirin-treated and untreated IL-15-activated NK cells to demonstrate if inhibitory effects on NK cell cytotoxicity induced by ribavirin can be reversed by tetrahydrobiopterin or NO addition. The results obtained show that addition of tetrahydrobiopterin or NO did not reverse the inhibitory effects of ribavirin on IL-15-activated NK cell cytotoxicity (Fig. 3 ).
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Ribavirin interferes with IL-15R expression and its associated downstream signaling events
The results from NK cell cytotoxicity showed that only IL-15-activated NK cells were Fig 4B) . Ribavirin did not inhibit Tyr phosphorylation of Jak-3 ( Fig   4B) . We also studied effect of ribavirin on IL-15 signaling after 18 h IL-15/ribavirin treatment of NK cells. The results obtained revealed the inhibition of Jak-1, STAT-1, STAT-3, but not Jak-3 and STAT-5 phosphorylation (Fig 4C) . IL-2Rβ and γ expression was also suppressed (not shown) after 18 h ribavirin treatment.
Ribavirin down-modulates NK cell activating receptor expression
NK cell cytotoxicity is critically dependent on signaling through its receptors, leading to granule polarization and exocytosis. Since IL-15 enhances NK cell cytotoxicity by upregulating the expression of NK receptors, it is conceivable that the inhibition of IL-15 signaling via IL-15Rβ and γ by ribavirin might lead to a suppressed expression of NK cell receptors responsible for cytotoxicity signals. To address these issues, we investigated the (Fig. 5A) . These results suggest that ribavirin acts directly on selected NK cell receptors rather than by interfering with NK cell binding to target cells.
Ribavirin suppresses NK cell receptor function
To assess whether ribavirin-induced down-modulation of NK cell activating receptors correlated with an alteration of receptor function, ribavirin-treated and untreated NK cells were compared in a redirected killing assay against FcγR + P815 target cell line. The FcγR + P815 cell line has been extensively used for mAb-mediated redirected killing assays using NK cells and mAbs capable of triggering their cytolytic functions [23, 29] . This would allow us assess in a cytolytic assay the direct effect of ribavirin on the specific activity of NK trigerring receptors. As shown in Fig. 6C and D).
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DISCUSSION
The data presented in this study show for the first time that ribavirin inhibits human NK cell function. Moreover, evidence is presented about the molecular mechanisms that underlie the immunomodulatory activities of ribavirin in NK cells. NK cells mediate host cell defenses by direct lysis of target cells and/or by production of IFN-γ [30] . Suppression of NK-cell cytotoxicity may be associated with the inhibition of IFN-γ production [26, 27] . Our results
show that while ribavirin had no effect on lytic activity of NK cells that are not treated with IL-15, it exerted a dose-dependent inhibition on the lytic activity of IL-15-treated NK cells.
Ribavirin also dose-dependently inhibited the production of IFN-γ in IL-15-activated NK cells. Although not shown, ribavirin also suppressed the function of IL-2-activated NK cells.
Remarkably, we found that NK cells from different donors can display different susceptibilities to ribavirin treatment in the presence of IL-15. Thus, in 2 of 15 donors, cytotoxicity and IFN-γ production was not inhibited by ribavirin treatment.
In an attempt to identify the possible mechanism by which ribavirin inhibits cytotoxicity of IL-15-activated NK cells, we investigated a mode of action that has been ascribed to ribavirin -the inhibition of tetrahydrobiopterin syntheis and hence NO synthesis inhibition [25, 28] . NO is a highly reactive free radical synthesized in vessel endothelium, immune cells, brain, and other tissues. NO-mediated cell death is prominent among the many paths the immune system uses to kill target cells [28, 35] . While some studies suggest that NO blocks activation of NK and cytotoxic T lymphocyte cells [36] [37] [38] , another report suggests that NO has no effect on lymphokine activated killer (LAK) cells [39] . Some more studies however showed that NO increases LAK activity A c c e p t e d M a n u s c r i p t   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 16 tetrahydrobiopterin alone did not influence NK cell lytic capacity treatment with NO alone significantly suppressed cytotoxicity of NK cells. These experiments were performed with highest non-toxic concentrations of tetrahydrobiopterin (10 µg/ml) and NO (5 µg/ml). Higher concentrations (tetrahydrobiopterin (20 µg/ml), NO (10 µg/ml)), turned out to be cytotoxic in NK cells.
Since It is well established that IL-15Rβ binds to Jak-1, which in turn, activates STAT-3 [13] . In this study, both Jak-1 and STAT-3 activation were inhibited by ribavirin. Therefore, ribavirin-induced inhibition of IL-15Rβ expression may lead to a weak/impaired IL-
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A c c e p t e d M a n u s c r i p t   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 17 15Rβ/Jak-1 association and subsequently to blocking of Jak-1 and STAT-3 activation. Also, IL-15Rγ binds to Jak-3, which in turn, activates STAT-5 [13] . The ligation of NK cell with its target rapidly causes a transient activation of ERK, which apparently control lytic granule movement [31] . Indeed, the activation of the mitogenactivated protein kinase (MAPK) pathways, ERK1/2 and JNK, by activating receptors like NKp46, CD16, 2B4, and NKG2D [15, 33] has been reported to play a pivotal role in NK cell cytotoxicity and granule polarization. ERK2 in particular was reported to be the final mediator of perforin and granzyme B granule polarization towards target cells [31] . JNK was shown to be implicated in the prevention of down-regulation of NKG2D expression in NK cells by transforming growth factor beta [34] . Notably, in the presence of ribavirin, the inhibition of ERK1/2 activation was observed. JNK activation was only moderately inhibited by ribavirin. Although IL-15 mainly phosphorylates ERK1/2, it also does phosphorylate JNK.
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In T cells, IL-15 phosphorylation of ERK and JNK was shown to be mediated by NKG2D, an NK activating receptor which is up-regulated by IL-15 [54, 55] . Furthermore NKG2D signaling in NK cells is known to be coupled to IL-15 signaling [20] . It is therefore conceivable that inhibition of NK activating receptors expression, which in turn leads to impaired receptor signaling, may delineate how ribavirin blocks ERK1/2 and JNK activation.
Additionally, inhibition of expression as well as a sharp decrease of release of perforin and granzyme B was detected in ribavirin-treated cells. IFN-production [59] . In the present study, effects of ribavirin on pathways upstream of MAPKs were not investigated. However, the inhibition of ERK1/2 and JNK phosphorylation in ribavirin treated NK cells may be relevant for inhibition of IFN-production.
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